TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Radiopharm Theranostics Limited ( (AU:RAD) ) has shared an announcement.
Radiopharm Theranostics Limited has announced its upcoming Annual General Meeting, scheduled for November 20, 2025, which will be held both in-person in Victoria and virtually via the Automic Investor Portal. This hybrid meeting format aims to accommodate all shareholders, allowing them to participate, vote, and ask questions about the company’s operations and business matters, thereby enhancing shareholder engagement and transparency.
The most recent analyst rating on (AU:RAD) stock is a Buy with a A$0.05 price target. To see the full list of analyst forecasts on Radiopharm Theranostics Limited stock, see the AU:RAD Stock Forecast page.
More about Radiopharm Theranostics Limited
Radiopharm Theranostics Limited operates in the healthcare industry, focusing on the development and commercialization of radiopharmaceutical products for diagnostic and therapeutic purposes. The company is dedicated to advancing precision medicine through innovative radiopharmaceutical solutions.
Average Trading Volume: 4,863,076
Technical Sentiment Signal: Buy
Current Market Cap: A$68.58M
Learn more about RAD stock on TipRanks’ Stock Analysis page.